Skip to main content

Table 1 Correlation between LASS2 expression and clinicopathological parameters in three tumors

From: LASS2 suppresses metastasis in multiple cancers by regulating the ferroptosis signalling pathway through interaction with TFRC

Characteristic

LASS2 ID score

Thyroid cancer

 

Breast cancer

 

Hepatocellular carcinoma

0–4

6–12

P value

0–4

6–12

P value

0–4

6–12

P value

Sex

  

0.366

Age (years)

  

0.597

Sex

  

0.63

 Male

7

10

 

    < 51

4

14

 

    Male

6

25

 

 Female

9

8

 

    ≥ 51

3

9

 

    Female

4

3

 

Age (years)

  

0.652

Tumor size

  

0.236

Age (years)

  

0.91

 < 55

14

16

 

    ≤ 2 cm

0

5

 

    < 50

1

11

 

 ≥ 55

2

2

 

    > 2 cm

7

18

 

≥ 50

9

17

 

Tumor size

  

0.023*

TNM stage

  

0.003*

TNM stage

  

0.014*

 ≤ 2 cm

8

16

 

    I

0

2

 

    I

0

5

 

 > 2 cm

8

2

 

    II

1

18

 

    II

4

19

 

LNM

  

0.030*

    III

3

2

 

    III

6

3

 

 Negative

2

9

 

    IV

3

1

 

    IV

0

1

 

 Positive

14

9

 

Metastases

  

0.031*

    
    

    Negative

3

1

     
    

    Positive

4

22

     
    

LNM

  

0.143

    
    

    Negative

3

17

     
    

    Positive

4

6

     
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us